Friday, May 29, 2020

WuXi AppTec: Collaborating Against COVID-19

WuXi AppTec is convening and working together with experts, from our company and around the world, for ongoing analysis of the COVID-19 pandemic. We are also partnering with other...

WuXi’s STA Biotech CMC Outsourcing Boston Symposium Recap

WuXi’s STA Pharmaceutical recently hosted a knowledge sharing and networking symposium, “Biotech CMC Outsourcing Strategies – Boston.” More than 100 industry CMC professionals and collaborators participated in this event, which focused...

A Personal Journey in Creating Breakthrough Treatments for Disease

By Rich Soll, SVP of Research Service Division at WuXi AppTec (@richsollwx) “As you toil and try to solve some scientific problems along the way, you’re so focused on solving some of...

WuXi Biologics Completes Construction of Asia’s Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreactors

We are pleased to announce the opening of our new commercial-scale cGMP biologics perfusion manufacturing facility in the city of Wuxi, China. The $150 million commercial biologics manufacturing facility accommodates two 1000L...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WuXi NEWS